RetinalGenix Technologies Inc.
RTGN
$4.00
$0.8025.00%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -19.57% | 7.25% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.29% | 9.56% | |||
| Operating Income | 5.29% | -9.56% | |||
| Income Before Tax | 5.23% | -9.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.23% | -9.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.23% | -9.55% | |||
| EBIT | 5.29% | -9.56% | |||
| EBITDA | 5.29% | -9.56% | |||
| EPS Basic | 5.69% | -9.15% | |||
| Normalized Basic EPS | 5.74% | -9.42% | |||
| EPS Diluted | 5.69% | -9.15% | |||
| Normalized Diluted EPS | 5.74% | -9.42% | |||
| Average Basic Shares Outstanding | 0.61% | 0.33% | |||
| Average Diluted Shares Outstanding | 0.61% | 0.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||